๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Vaxjo
Clinical trial register · Sweden

Clinical Trials in Vaxjo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2213 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2213
Studies in scope
all four open statuses
1238
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 32 Uppsala 25 Lund 21 Gothenburg 20 Linkรถping 15
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm32 Uppsala25 Lund21 Gothenburg20 Linkรถping15
All 32 locations
Target enrolment
to

Trials with a site in Vaxjo

3 of 2213 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723Chronic Kidney Disease and Hypertension
AstraZeneca
Phase 3
5,000
Huddinge, Karlstad, Linkรถping, Stockholm, Uppsala, Vaxjo
2025-03-03
Active, closed
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
NCT04784715Breast Cancer; HER2-positive; Metastatic
AstraZeneca
Phase 3
1,157
Gothenburg, ร–rebro, Stockholm, Uppsala, Vaxjo
2021-04-26
Active, closed
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
NCT04494425Advanced or Metastatic Breast Cancer
AstraZeneca
Phase 3
866
Gothenburg, ร–rebro, Stockholm, Uppsala, Vaxjo
2020-07-24
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-sweden/city/vaxjo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,213 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies with a site in Vaxjo that also match the filters currently applied.

How many clinical trials are recruiting in Vaxjo?

1 of the 3 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Vaxjo), 3 studies
PhaseStudiesRecruitingShare
Phase 331100%

Most active sponsors

Lead sponsors with the most studies (Vaxjo)
Lead sponsorStudiesRecruiting
AstraZeneca31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.